Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Active, not recruiting	Phase 2	2026-09-29		NCT05354557

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Memorial Sloan Kettering Cancer Center	753

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Memorial Sloan Kettering Basking Ridge (Consent and Followup)	Basking Ridge	United States	3
Memorial Sloan Kettering Bergen (Consent and Follow up)	Montvale	United States	5
Memorial Sloan Kettering Cancer Center (All Protocol Activities)	New York	United States	230
Memorial Sloan Kettering Monmouth (Consent and Follow-Up only)	Middletown	United States	4
Memorial Sloan Kettering Nassau (Consent and Followup)	Rockville Centre	United States	3
Memorial Sloan Kettering Suffolk-Commack (Consent and Follow up)	Commack	United States	1
Memorial Sloan Kettering Westchester (Consent and Follow up)	Harrison	United States	4
Weill Cornell Medical College (Data Collection Only)	New York	United States	1